Merakris Therapeutics, a clinical-stage Research Triangle Park regenerative biologic medicines company, has received a $2.2 million federal grant to advance commercialization of a diabetic food ulcer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results